Related Experiment Video
Updated: Apr 16, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
The STING pathway and the T cell-inflamed tumor microenvironment
Seng-Ryong Woo1, Leticia Corrales1, Thomas F Gajewski2
1Department of Pathology, The University of Chicago, Chicago, IL, USA.
Certain advanced solid tumors have a T cell-inflamed microenvironment, crucial for immunotherapy response. Understanding spontaneous T cell generation mechanisms, like the STING pathway, is key to developing new cancer immunotherapies.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- A subset of patients with advanced solid tumors exhibits a spontaneous T cell-inflamed tumor microenvironment.
- This microenvironment is prognostically significant and correlates with clinical responses to immunotherapies.
- Understanding the mechanisms behind spontaneous T cell responses is critical for advancing cancer immunotherapy.
Purpose of the Study:
- To discuss the characteristics differentiating T cell-inflamed from non-inflamed tumors.
- To review the role of the type I interferon (IFN) signature in T cell priming against tumor antigens.
- To highlight the STING pathway as a key innate immune sensor driving type I IFN production in tumors.
Main Methods:
- Review of existing literature on tumor microenvironment characteristics.
- Analysis of findings related to type I interferon signatures in tumors.
- Examination of recent research on the STING pathway in the context of cancer immunology.
Main Results:
- T cell-inflamed tumors possess distinct characteristics compared to non-inflamed tumors.
- A type I interferon (IFN) signature is associated with T cell priming against tumor antigens.
- The STING (stimulator of interferon genes) pathway is identified as a crucial innate immune sensor for type I IFN production in the tumor microenvironment.
Conclusions:
- The STING pathway's role in cytosolic DNA sensing is pivotal for type I IFN production in tumors.
- Understanding this pathway is essential for developing novel immunotherapeutic strategies.
- Targeting the STING pathway may enhance T cell responses and improve immunotherapy outcomes in cancer patients.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Tumor Immunotherapy
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

